Related Experiment Video
Updated: Jul 5, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Oral antibiotics decrease urinary isoflavonoid excretion in children after soy consumption
Brunhild M Halm1, Adrian A Franke, Leslie A Ashburn
1Cancer Research Center of Hawai'i, Cancer Prevention & Control Program and Kapi'olani Medical Center for Women and Children, Honolulu, HI 96813, USA.
Insights
Oral antibiotics (OABX) significantly reduce urinary isoflavone excretion rates (UIERs) in soy-consuming children. This suggests OABX alter gut bacteria, impacting how the body processes beneficial soy compounds.
Area of Science:
- Human Nutrition and Metabolism
- Microbiology and Gut Health
- Pharmacology
Background:
- Isoflavones (IFLs) are plant compounds found in soy with potential health benefits.
- The gut microbiome plays a crucial role in metabolizing IFLs.
- The impact of oral antibiotics (OABX) on IFL metabolism in children is not well understood.
Purpose of the Study:
- To investigate how OABX affect urinary isoflavone excretion rates (UIERs) in children who consume soy.
- To explore the potential role of gut microflora alterations in mediating these effects.
Main Methods:
- A cohort of 11 children (ages 4-17) provided paired urine samples: one during OABX treatment and one when healthy.
- Participants consumed a standardized dose of soy nuts.
- Urinary IFLs (nonmetabolites and metabolites) were quantified using liquid chromatography-mass spectrometry.
Main Results:
- Urinary excretion rates for genistein (GE), other nonmetabolite IFLs, and total IFLs were significantly lower during OABX treatment compared to when healthy (P < 0.05).
- A trend towards increased O-desmethylangolensin (DMA) production was observed during OABX use (P = 0.13).
- Reduced IFLs in urine may be linked to OABX-induced changes in gut bacteria or infection-related processes.
Conclusions:
- Oral antibiotic use significantly decreases the urinary excretion of isoflavones in soy-consuming children.
- This reduction highlights the influence of the gut microbiome on IFL bioavailability and metabolism.
- Further research is needed to fully elucidate the mechanisms behind OABX-mediated changes in IFL processing.
Abstract:
How oral antibiotics (OABX) alter isoflavones (IFLs) in soy-consuming children is unknown. We evaluated OABX effects on urinary IFL excretion rates (UIERs) in 17 children, ages 4 to 17 yr, who provided 2 urine collections in pairs of a baseline urine and an overnight urine collection after consuming a body-weight-adjusted dose of soy nuts. The first collection was during OABX treatment for a bacterial infection and the second when healthy and off antibiotics. IFL food levels and UIERs were measured for nonmetabolites (NM), namely, daidzein, genistein (GE), and glycitein, and the metabolites (M) dihydrodaidzein, dihydrogenistein, equol, and O-desmethylangolensin (DMA), by liquid chromatography mass spectrometry. Urinary IFLs were hypothesized to change after OABX due to intestinal microflora alterations. A total of 11 children completed the study correctly. During OABX use, UIER (nmol/h/kg) for GE (6.4 +/- 1.0 vs. 10.1 +/- 1.6), all NM (27.5 +/- 4.8 vs. 36.2 +/- 4.7), and total IFLs (all NM + all M; 29.4 +/- 5.0 vs. 38.8 +/- 4.8) was reduced (P < 0.05) vs. when healthy. In contrast, a trend toward more DMA production during OABX was observed (1.2 +/- 0.6 vs. 0.4 +/- 0.3, P = 0.13). The reduction in urinary IFL appearance could be due to the changes of intestinal bacteria by OABX and/or due to processes related to the infection.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Cancer Prevention
Some...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care